Medicare's $50 GLP-1 Drug Copay Excludes Key Benefits
Starting July 1, eligible Medicare Part D enrollees can access weight-loss drugs like Wegovy and Zepbound for a flat $50 monthly copay through the temporary Medicare GLP-1 Bridge. However, this benefit operates outside traditional Part D coverage rules, meaning it does not count toward annual deductibles or out-of-pocket caps.